Active pharmaceutical ingredient (API) production involving continuous processes - A process system engineering (PSE)-assisted design framework.

Department of Chemical and Biochemical Engineering, Technical University of Denmark (DTU), Building 229, DK-2800 Kgs. Lyngby, Denmark.
European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V (Impact Factor: 4.25). 07/2012; 82(2):437-56. DOI: 10.1016/j.ejpb.2012.07.001
Source: PubMed

ABSTRACT A systematic framework is proposed for the design of continuous pharmaceutical manufacturing processes. Specifically, the design framework focuses on organic chemistry based, active pharmaceutical ingredient (API) synthetic processes, but could potentially be extended to biocatalytic and fermentation-based products. The method exploits the synergic combination of continuous flow technologies (e.g., microfluidic techniques) and process systems engineering (PSE) methods and tools for faster process design and increased process understanding throughout the whole drug product and process development cycle. The design framework structures the many different and challenging design problems (e.g., solvent selection, reactor design, and design of separation and purification operations), driving the user from the initial drug discovery steps - where process knowledge is very limited - toward the detailed design and analysis. Examples from the literature of PSE methods and tools applied to pharmaceutical process design and novel pharmaceutical production technologies are provided along the text, assisting in the accumulation and interpretation of process knowledge. Different criteria are suggested for the selection of batch and continuous processes so that the whole design results in low capital and operational costs as well as low environmental footprint. The design framework has been applied to the retrofit of an existing batch-wise process used by H. Lundbeck A/S to produce an API: zuclopenthixol. Some of its batch operations were successfully converted into continuous mode, obtaining higher yields that allowed a significant simplification of the whole process. The material and environmental footprint of the process - evaluated through the process mass intensity index, that is, kg of material used per kg of product - was reduced to half of its initial value, with potential for further reduction. The case-study includes reaction steps typically used by the pharmaceutical industry featuring different characteristic reaction times, as well as L-L separation and distillation-based solvent exchange steps, and thus constitutes a good example of how the design framework can be useful to efficiently design novel or already existing API manufacturing processes taking advantage of continuous processes.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The major part of the production costs of pharmaceuticals can be imputed to the downstream processing, where membrane technologies have to deal with some challenges as separations involving solutes with similar sizes or solvent recovery and recycling. This work contributes to the progress in the design of continuous organic solvent nanofiltration systems for this purpose and includes the configuration of dual membrane cascades, sensitivity analysis of the operation variables, and economic optimization as innovations. Analyzed configurations include multistage cascades up to three stages, and dual membrane cascades up to five stages. The total costs were chosen as the formulated objective function to minimize in the economic optimization strategy. The treatment of the residual stream leaving the system resulted the main cost of the process (more than 85% for dual cascades), but the solvent recovery units can significantly reduce the total costs (64 to 77% depending on the required solvent quality). © 2013 American Institute of Chemical Engineers AIChE J, 2013
    AIChE Journal 03/2014; 60:931-938. DOI:10.1002/aic.14345 · 2.58 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A novel manufacturing strategy based on continuous processing integrated with online/inline monitoring tools coupled with an advanced control system is highly desired for efficient Quality by Design (QbD)-based pharmaceutical manufacturing. A control system ensures the predefined end product quality, satisfies the high regulatory constraints, facilitates real time release of the product, and optimizes the resources. In this work, a systematic framework for the onsite design and implementation of the control system in continuous tablet manufacturing process has been developed. The framework includes a generic methodology and supporting tools through which the control system can be designed at the manufacturing site and can be implemented for closed-loop operation. The control framework has different novel features such as the option to run the plant in closed-loop (MPC/PID), open-loop and simulation mode. NIR sensor, an online prediction tool, a PAT data management tool, and a control platform have been used to close the control loop.
    Computers & Chemical Engineering 07/2014; DOI:10.1016/j.compchemeng.2014.02.029 · 2.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The development and operation of the synthesis and workup steps of a fully integrated, continuous manufacturing plant for synthesizing aliskiren, a small molecule pharmaceutical, are presented. The plant started with advanced intermediates, two synthetic steps away from the final active pharmaceutical ingredient, and ended with finished tablets. The entire process was run on several occasions, with the data presented herein corresponding to a 240 h run at a nominal throughput of 41 g h−1 of aliskiren. The first reaction was performed solvent-free in a molten condition at a high temperature, achieving high yields (90%) and avoiding solid handling and a long residence time (due to higher concentrations compared to dilute conditions when run at lower temperatures in a solvent). The resulting stream was worked-up inline using liquid−liquid extraction with membrane-based separators that were scaled-up from microfluidic designs. The second reaction involved a Boc deprotection, using aqueous HCl that was rapidly quenched with aqueous NaOH using an inline pH measurement to control NaOH addition. The reaction maintained high yields (90−95%) under closed-loop control despite process disturbances.
    Organic Process Research & Development 03/2014; DOI:10.1021/op400294z · 2.55 Impact Factor